Dexamethasone for respiratory insufficiency

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 14 Apr 2020: Trial registered, NCT04344730

The trials

NCT04344730: Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia

State
State not given
Phase
No phase
People
550 taking part
Started
10 Apr 2020
Primary completion
31 Dec 2021
Arms
Standard oxygen 2, mechanically ventilated 2
Results
None posted
  1. 10 Apr 2020: Trial started
  2. 14 Apr 2020: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Also known as Aeroseb-dex, Ciprodex component dexamethasone, Decaderm, Decadron, Decaspray, Dexa-sine, Dexacidin component dexamethasone, Dexacortal, Dexacortin, Dexamonozon, Dexapos, Dexasite, Dexasone, Dexasporin component dexamethasone, Dexone, Dextenza, Dexycu, Dexamethasone injection, Fortecortin, Hemady, Hexadrol, Isopto-dex, Loverine, Luxazone, Maxidex, Maxitrol component dexamethasone, Ozurdex, Tobradex component dexamethasone, Tobradex st component dexamethasone.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.